CooperCompanies appoints former STERIS CEO Rosebrough to board; agrees with Browning West

COOPER COMPANIES, INC.

Walter M. Rosebrough Jr., former STERIS CEO, appointed as independent director effective Jan 3, 2026; joins Governance & Nominating Committee.
Board will consider appointing Rosebrough as Chair by end of 2026 and add another independent director with medtech experience by June 30, 2026, subject to Browning West approval.
Cooperation agreement with Browning West includes customary standstill and voting commitments through 30 days before 2027 annual meeting deadline.
Rosebrough led STERIS from 2007-2021, delivering 18% annualized total return and growing market cap by over $20B.
Incoming Board Chair Colleen Jay welcomes the appointment; Browning West's CIO Usman Nabi calls it a constructive path forward.

item 1.01 item 5.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.7

COOPER COMPANIES, INC. entered into Agreement with Browning West, LP (effective 2025-12-22).

Action: entry
Counterparty: Browning West, LP
Effective: 2025-12-22

Exact text from the filing

On December 22, 2025, The Cooper Companies, Inc. (the “Company”) entered into a letter agreement (the “Agreement”) with Browning West, LP (including the funds managed by it, “Browning West”).

View on SEC.gov

Browse all material agreements →

COOPER COMPANIES, INC. filing history →

Source: SEC EDGAR

accession 0001193125-25-331117

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.